Mario Ouwens

1.6k total citations
67 papers, 904 citations indexed

About

Mario Ouwens is a scholar working on Statistics and Probability, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mario Ouwens has authored 67 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Statistics and Probability, 17 papers in Economics and Econometrics and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mario Ouwens's work include Statistical Methods in Clinical Trials (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Mario Ouwens is often cited by papers focused on Statistical Methods in Clinical Trials (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Mario Ouwens collaborates with scholars based in United Kingdom, Sweden and United States. Mario Ouwens's co-authors include Jeroen P. Jansen, Martijn P. F. Berger, Z Philips, Frans E. S. Tan, Susan Grandy, Kristina Johnsson, Karel Kostev, Qing Qiao, Yiduo Zhang and Pralay Mukhopadhyay and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Mario Ouwens

61 papers receiving 868 citations

Peers

Mario Ouwens
Amr Makady Netherlands
Louis Dron Canada
Jakob Ribbing Sweden
MO Karlsson Sweden
Chuanpu Hu United States
Sandrine Micallef France
Shannon Cope United States
Wayne Ewy United States
Diane Potvin United States
Gene Pennello United States
Amr Makady Netherlands
Mario Ouwens
Citations per year, relative to Mario Ouwens Mario Ouwens (= 1×) peers Amr Makady

Countries citing papers authored by Mario Ouwens

Since Specialization
Citations

This map shows the geographic impact of Mario Ouwens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Ouwens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Ouwens more than expected).

Fields of papers citing papers by Mario Ouwens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Ouwens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Ouwens. The network helps show where Mario Ouwens may publish in the future.

Co-authorship network of co-authors of Mario Ouwens

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Ouwens. A scholar is included among the top collaborators of Mario Ouwens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Ouwens. Mario Ouwens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munter, Leonie de, Wilhelmine Meeraus, Chloé Wyndham-Thomas, et al.. (2025). Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case–control study. European Journal of Public Health. 35(2). 373–378.
2.
3.
McEwan, Phil, Jason A. Davis, Juan José García Sánchez, et al.. (2024). The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis. Nephrology Dialysis Transplantation. 39(12). 2040–2047. 8 indexed citations
4.
Johnston, S. Claiborne, Ritika Jain, Pierre Amarenco, et al.. (2023). Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial. BMJ Neurology Open. 5(2). e000478–e000478.
5.
Manyara, Anthony Muchai, Philippa Davies, Derek Stewart, et al.. (2023). Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review. Journal of Clinical Epidemiology. 160. 83–99. 12 indexed citations
6.
Ouwens, Mario, Andrew Briggs, Hiddo J.L. Heerspink, et al.. (2023). The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial. Advances in Therapy. 40(6). 2741–2751. 5 indexed citations
7.
8.
Nordon, Clémentine, Kirsty Rhodes, Jennifer K Quint, et al.. (2023). EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies. BMJ Open. 13(4). e070022–e070022. 16 indexed citations
9.
Manyara, Anthony Muchai, Philippa Davies, Derek Stewart, et al.. (2022). Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open. 12(10). e064304–e064304. 12 indexed citations
10.
Harari, Ofir, et al.. (2022). Network meta‐interpolation: Effect modification adjustment in network meta‐analysis using subgroup analyses. Research Synthesis Methods. 14(2). 211–233. 7 indexed citations
11.
Rhodes, Kirsty, Martin Jenkins, Enrico De Nigris, Magnus Aurivillius, & Mario Ouwens. (2022). Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study. BMC Medical Research Methodology. 22(1). 150–150. 7 indexed citations
12.
13.
14.
Ouwens, Mario, Annie Darilay, P. Mukhopadhyay, et al.. (2019). Impact of subsequent post-discontinuation immunotherapy on overall survival in patients with unresectable, stage III NSCLC from PACIFIC. Annals of Oncology. 30. ii31–ii31. 1 indexed citations
15.
Hashim, Mahmoud, et al.. (2019). Extrapolating Survival Data Using Historical Trial–Based a Priori Distributions. Value in Health. 22(9). 1012–1017. 22 indexed citations
16.
Sauboin, Christophe, Paolo Bonanni, Mario Ouwens, et al.. (2012). PIN46 Pharmacoeconomic Evaluation of the Introduction of Universal Varicella Vaccination in Italy. Value in Health. 15(7). A393–A393. 1 indexed citations
17.
Cope, Shannon, Gorana Capkun-Niggli, Cheryl Lassen, et al.. (2012). Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison. Value in Health. 15(3). 524–533. 11 indexed citations
18.
Guyot, Patricia, Nicky J. Welton, Mario Ouwens, & A. E. Ades. (2011). Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness. Value in Health. 14(5). 640–646. 31 indexed citations
19.
Ouwens, Mario, et al.. (2011). PIH5 Replacing MMR By MMRV in Mexico: Assessement of Cost-Effectiveness Based on a Dynamic Transmission Model. Value in Health. 14(7). A558–A558. 1 indexed citations
20.
Ouwens, Mario, et al.. (2002). Maximin D-Optimal Designs for Longitudinal Mixed Effects Models. Biometrics. 58(4). 735–741. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amr Makady Breakdown of academic impact, for papers by Louis Dron Breakdown of academic impact, for papers by Jakob Ribbing Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by Chuanpu Hu Breakdown of academic impact, for papers by Sandrine Micallef Breakdown of academic impact, for papers by Shannon Cope Breakdown of academic impact, for papers by Wayne Ewy Breakdown of academic impact, for papers by Diane Potvin Breakdown of academic impact, for papers by Gene Pennello
Rankless by CCL
2026